CRBP
Price
$7.71
Change
-$0.04 (-0.52%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
94.83M
ITRM
Price
$0.96
Change
-$0.01 (-1.03%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
38.98M
36 days until earnings call
Interact to see
Advertisement

CRBP vs ITRM

Header iconCRBP vs ITRM Comparison
Open Charts CRBP vs ITRMBanner chart's image
Corbus Pharmaceuticals Holdings
Price$7.71
Change-$0.04 (-0.52%)
Volume$4.99K
Capitalization94.83M
Iterum Therapeutics
Price$0.96
Change-$0.01 (-1.03%)
Volume$614
Capitalization38.98M
CRBP vs ITRM Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. ITRM commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongBuy and ITRM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CRBP: $7.75 vs. ITRM: $0.97)
Brand notoriety: CRBP and ITRM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 167% vs. ITRM: 80%
Market capitalization -- CRBP: $94.83M vs. ITRM: $38.98M
CRBP [@Biotechnology] is valued at $94.83M. ITRM’s [@Biotechnology] market capitalization is $38.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileITRM’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • ITRM’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBP is a better buy in the long-term than ITRM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while ITRM’s TA Score has 3 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 4 bearish.
  • ITRM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than ITRM.

Price Growth

CRBP (@Biotechnology) experienced а -10.61% price change this week, while ITRM (@Biotechnology) price change was -6.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

CRBP is expected to report earnings on May 06, 2025.

ITRM is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($94.8M) has a higher market cap than ITRM($39M). CRBP YTD gains are higher at: -34.322 vs. ITRM (-45.311). ITRM has higher annual earnings (EBITDA): -19.12M vs. CRBP (-48.74M). CRBP has more cash in the bank: 133M vs. ITRM (12.7M). CRBP has less debt than ITRM: CRBP (2.86M) vs ITRM (32M). CRBP (0) and ITRM (0) have equivalent revenues.
CRBPITRMCRBP / ITRM
Capitalization94.8M39M243%
EBITDA-48.74M-19.12M255%
Gain YTD-34.322-45.31176%
P/E RatioN/AN/A-
Revenue00-
Total Cash133M12.7M1,047%
Total Debt2.86M32M9%
FUNDAMENTALS RATINGS
CRBP vs ITRM: Fundamental Ratings
CRBP
ITRM
OUTLOOK RATING
1..100
5662
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6385
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRBP's Valuation (50) in the Biotechnology industry is somewhat better than the same rating for ITRM (88). This means that CRBP’s stock grew somewhat faster than ITRM’s over the last 12 months.

CRBP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ITRM (100). This means that CRBP’s stock grew similarly to ITRM’s over the last 12 months.

CRBP's SMR Rating (96) in the Biotechnology industry is in the same range as ITRM (100). This means that CRBP’s stock grew similarly to ITRM’s over the last 12 months.

CRBP's Price Growth Rating (63) in the Biotechnology industry is in the same range as ITRM (85). This means that CRBP’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for CRBP (100). This means that ITRM’s stock grew significantly faster than CRBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRBPITRM
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 24 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICHR22.321.24
+5.88%
Ichor Holdings
ZWS37.540.13
+0.35%
Zurn Elkay Water Solutions Corp
CCG0.76N/A
N/A
Cheche Group
MDT88.28-0.47
-0.53%
Medtronic plc
BNED11.48-0.21
-1.80%
Barnes & Noble Education

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
+8.24%
SKYE - CRBP
46%
Loosely correlated
+11.50%
FBIO - CRBP
38%
Loosely correlated
+1.54%
STOK - CRBP
37%
Loosely correlated
-0.86%
APLS - CRBP
35%
Loosely correlated
-0.31%
CCCC - CRBP
30%
Poorly correlated
+0.66%
More